Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy
Integrating Tobacco Cessation Coaching Sessions Into Radiation Medicine Treatment: A Pilot Study
Descripción general del estudio
Estado
Condiciones
Descripción detallada
PRIMARY OBJECTIVES:
I. To determine if training providers on tobacco cessation resources increases the frequency of counseling and referrals at initial and follow-up consultations for cancer patients who use tobacco and are scheduled to receive radiation at Oregon Health and Science University (OHSU).
SECONDARY OBJECTIVES:
I. Increase provider frequency of tobacco use quantification and type. II. Increase frequency of provider assessment of tobacco cessation readiness in current users.
III. Increase frequency and types of tobacco cessation resources and medicines offered and utilized.
IV. Increase frequency and type of follow-up planned if referred to cessation resource.
OUTLINE:
MEDICAL CHART REVIEW: Medical charts from patients with diagnoses of head and neck cancer, lung cancer, prostate cancer, or breast cancer are reviewed at months 1-12 to determine the frequency of tobacco assessments and documentation of discussions with patients regarding tobacco use and utilization of cessation resources as before and after the proposed training.
PROVIDER TRAINING: Providers undergo training to use patient coaching such as the 5A's (Ask, Advise, Assess, Assist, and Arrange), to conduct regular tobacco intake assessment using motivational interviewing techniques. Providers also undergo training to use public/community tobacco cessation resources for patients ready to quit within six weeks, and have access to pharmacy residents for ad-hoc prescribing questions.
PATIENT COACHING: Patients attend 4 phone or in-person motivational interviewing coaching sessions over 30-45 minutes for 6-8 weeks or longer as needed.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Oregon
-
Portland, Oregon, Estados Unidos, 97239
- OHSU Knight Cancer Institute
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- MEDICAL CHART REVIEW
- Pre-intervention: 200 patient records between January 1, 2016 and December 31, 2016 are subject to review; the first 50 records with a diagnoses of each cancer type: head and neck, lung, prostate, or breast will be utilized for the review
- Post-intervention: 200 patient records receiving care beginning six months post training are subject to review; the first 50 records with a diagnoses of head and neck, lung, prostate, or breast will be utilized
- PROVIDER TRAINING
- OHSU Radiation Medicine department has agreed to participate as pilot department for this project; all active Radiation Medicine providers are requested to participate in the training; providers have the option to not participate
- TOBACCO CESSATION COACHING
- Patients who are at least 18 years of age
- Speak English
- Report tobacco use within the past 7 days
- Willing to consider quitting smoking
- Patients must be willing to meet four times in person or on the phone to discuss tobacco use
- Patients must be willing to be audio recorded during the sessions
- Patients who meet this criteria will be referred to OHSU Health Promotion Sports Medicine researcher, Carol DeFrancesco, to complete assessment using stages of change tobacco use readiness ruler and question set
- Patient smoking status will be documented in their electronic health record, per routine care
Exclusion Criteria:
Vulnerable Populations
The following groups will be excluded from participation:
- Children
- Decisionally impaired adults
- Prisoners
- Pregnant women
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Health Services Research (Chart review, training, coaching)
MEDICAL CHART REVIEW: Medical charts from patients with diagnoses of head and neck cancer, lung cancer, prostate cancer, or breast cancer are reviewed at months 1-12 to determine the frequency of tobacco assessments and documentation of discussions with patients regarding tobacco use and utilization of cessation resources as before and after the proposed training. PROVIDER TRAINING: Providers undergo training to use patient coaching such as the 5A's (Ask, Advise, Assess, Assist, and Arrange), to conduct regular tobacco intake assessment using motivational interviewing techniques. Providers also undergo training to use public/community tobacco cessation resources for patients ready to quit within six weeks, and have access to pharmacy residents for ad-hoc prescribing questions. PATIENT COACHING: Patients attend 4 phone or in-person motivational interviewing coaching sessions over 30-45 minutes for 6-8 weeks or longer as needed. |
Estudios complementarios
Undergo motivational interviewing training
Undergo medical chart review
Otros nombres:
Attend phone or in-person motivational interviewing coaching sessions
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in frequency of tobacco counsel
Periodo de tiempo: Baseline up to 24 months
|
Will be compared between the cohort of pre and post intervention.
Will be summarized using descriptive statistics and compared using chi-square test by tumor type.
|
Baseline up to 24 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in frequency and type of follow-up planned if referred to cessation resource assessed by medical chart review
Periodo de tiempo: Baseline up to 24 months
|
Will be summarized using descriptive statistics and compared using chi-square test by tumor type.
|
Baseline up to 24 months
|
|
Change in frequency and types of tobacco cessation resources and medicines offered and utilized assessed by medical chart review
Periodo de tiempo: Baseline up to 24 months
|
Will be tested using a chi-squared test.
If any expected cell count in the contingency table is lower than 5, we will instead use Fisher's exact test.
|
Baseline up to 24 months
|
|
Change in frequency of provider assessment of tobacco cessation readiness in current users assessed by medical chart review
Periodo de tiempo: Baseline up to 24 months
|
Will be summarized using descriptive statistics and compared using chi-square test by tumor type.
|
Baseline up to 24 months
|
|
Change in provider frequency of tobacco use quantification and type assessed by medical chart review
Periodo de tiempo: Baseline up to 24 months
|
Will be summarized using descriptive statistics and compared using chi-square test by tumor type.
Will be tested using Z tests of proportion.
|
Baseline up to 24 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: John Holland, OHSU Knight Cancer Institute
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- STUDY00016428 (Otro identificador: OHSU Knight Cancer Institute)
- NCI-2017-00576 (Identificador de registro: CTRP (Clinical Trial Reporting Program))
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre El consumo de tabaco
-
Nanfang Hospital of Southern Medical UniversityShenzhen People's Hospital; Second Affiliated Hospital of Guangzhou Medical UniversityAún no reclutandoLesiones Pancreáticas Sólidas | USE-FNB
-
Asan Medical CenterDesconocidoUSE-PAAF | CitodiagnósticoCorea, república de
-
University of California, DavisAún no reclutandoBiopsia | Biopsia guiada por USE | Diagnóstico de un trastorno pancreatobiliarEstados Unidos
-
Cairo UniversityAún no reclutandoProtector bucal use lesiones orofaciales prevención de protección bucal impresaEgipto
-
University of TehranReclutamientoPancreatitis Aguda | Biopsia guiada por USEIrán
-
Milton S. Hershey Medical CenterNational Cancer Institute (NCI)TerminadoQuiste pancreático | USE-PAAFEstados Unidos
-
Assiut UniversityAún no reclutandoTomografía computarizada | Biopsia guiada por USE | Lesiones Pancreáticas Localizadas en el Cuerpo o la Cola
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityTerminadoCáncer de recto | USE-PAAF | Remisión Patológica CompletaPorcelana
-
National Cheng-Kung University HospitalDesconocidoMétodo de succión húmeda basado en heparina en EUS Biopsia con aguja fina de masa pancreática sólidaNeoplasias pancreáticas | Ultrasonografía endoscópica | USE-PAAFTaiwán
Ensayos clínicos sobre Administración del Cuestionario
-
Washington University School of MedicineTerminadoFilariasis linfatica | Oncocercosis | Infecciones por helmintos transmitidos por el suelo (STH)Liberia